OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Oncolytic Adenoviruses for Cancer Immunotherapy
Vincenzo Cerullo, Anniina Koski, Markus Vähä‐Koskela, et al.
Advances in cancer research (2012), pp. 265-318
Closed Access | Times Cited: 68
Vincenzo Cerullo, Anniina Koski, Markus Vähä‐Koskela, et al.
Advances in cancer research (2012), pp. 265-318
Closed Access | Times Cited: 68
Showing 1-25 of 68 citing articles:
Adenovirus Vectors for Gene Therapy, Vaccination and Cancer Gene Therapy
William S.M. Wold, Károly Tóth
Current Gene Therapy (2014) Vol. 13, Iss. 6, pp. 421-433
Open Access | Times Cited: 496
William S.M. Wold, Károly Tóth
Current Gene Therapy (2014) Vol. 13, Iss. 6, pp. 421-433
Open Access | Times Cited: 496
Adenovirus: The First EffectiveIn VivoGene Delivery Vector
Ronald G. Crystal
Human Gene Therapy (2014) Vol. 25, Iss. 1, pp. 3-11
Open Access | Times Cited: 304
Ronald G. Crystal
Human Gene Therapy (2014) Vol. 25, Iss. 1, pp. 3-11
Open Access | Times Cited: 304
Oncolytic viruses as therapeutic cancer vaccines
David L. Bartlett, Zuqiang Liu, Magesh Sathaiah, et al.
Molecular Cancer (2013) Vol. 12, Iss. 1
Open Access | Times Cited: 285
David L. Bartlett, Zuqiang Liu, Magesh Sathaiah, et al.
Molecular Cancer (2013) Vol. 12, Iss. 1
Open Access | Times Cited: 285
Trial watch
Erika Vacchelli, Alexander Eggermont, Catherine Sautès‐Fridman, et al.
OncoImmunology (2013) Vol. 2, Iss. 6, pp. e24612-e24612
Open Access | Times Cited: 250
Erika Vacchelli, Alexander Eggermont, Catherine Sautès‐Fridman, et al.
OncoImmunology (2013) Vol. 2, Iss. 6, pp. e24612-e24612
Open Access | Times Cited: 250
Armed Oncolytic Adenovirus–Expressing PD-L1 Mini-Body Enhances Antitumor Effects of Chimeric Antigen Receptor T Cells in Solid Tumors
Kiyonori Tanoue, Amanda Rosewell Shaw, Norihiro Watanabe, et al.
Cancer Research (2017) Vol. 77, Iss. 8, pp. 2040-2051
Open Access | Times Cited: 199
Kiyonori Tanoue, Amanda Rosewell Shaw, Norihiro Watanabe, et al.
Cancer Research (2017) Vol. 77, Iss. 8, pp. 2040-2051
Open Access | Times Cited: 199
Recent advances of oncolytic virus in cancer therapy
Moumita Mondal, Jingao Guo, Ping He, et al.
Human Vaccines & Immunotherapeutics (2020) Vol. 16, Iss. 10, pp. 2389-2402
Open Access | Times Cited: 167
Moumita Mondal, Jingao Guo, Ping He, et al.
Human Vaccines & Immunotherapeutics (2020) Vol. 16, Iss. 10, pp. 2389-2402
Open Access | Times Cited: 167
Oncolytic virus therapy in cancer: A current review
Jonathan Santos Apolonio, Vinícius Lima de Souza Gonçalves, Maria Luísa Cordeiro Santos, et al.
World Journal of Virology (2021) Vol. 10, Iss. 5, pp. 229-255
Open Access | Times Cited: 105
Jonathan Santos Apolonio, Vinícius Lima de Souza Gonçalves, Maria Luísa Cordeiro Santos, et al.
World Journal of Virology (2021) Vol. 10, Iss. 5, pp. 229-255
Open Access | Times Cited: 105
Oncolytic Virotherapy: A New Paradigm in Cancer Immunotherapy
Simona Ruxandra Volovăț, Dragoş Viorel Scripcariu, Ingrid-Andrada Vasilache, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1180-1180
Open Access | Times Cited: 20
Simona Ruxandra Volovăț, Dragoş Viorel Scripcariu, Ingrid-Andrada Vasilache, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1180-1180
Open Access | Times Cited: 20
Oncolytic Adenoviral Delivery of an EGFR-Targeting T-cell Engager Improves Antitumor Efficacy
Carlos Alberto Fajardo, Sònia Guedan, Luis A. Rojas, et al.
Cancer Research (2017) Vol. 77, Iss. 8, pp. 2052-2063
Open Access | Times Cited: 139
Carlos Alberto Fajardo, Sònia Guedan, Luis A. Rojas, et al.
Cancer Research (2017) Vol. 77, Iss. 8, pp. 2052-2063
Open Access | Times Cited: 139
Trial Watch—Oncolytic viruses and cancer therapy
Jonathan Pol, Aitziber Buqué, Fernando Aranda, et al.
OncoImmunology (2015) Vol. 5, Iss. 2, pp. e1117740-e1117740
Open Access | Times Cited: 103
Jonathan Pol, Aitziber Buqué, Fernando Aranda, et al.
OncoImmunology (2015) Vol. 5, Iss. 2, pp. e1117740-e1117740
Open Access | Times Cited: 103
TNFSF14: LIGHTing the Way for Effective Cancer Immunotherapy
Joseph G. Skeate, Mikk E. Otsmaa, Ruben Prins, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 80
Joseph G. Skeate, Mikk E. Otsmaa, Ruben Prins, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 80
Combination therapy with CAR T cells and oncolytic viruses: a new era in cancer immunotherapy
Ramazan Rezaei, Hadi Esmaeili Gouvarchin Ghaleh, Mahdieh Farzanehpour, et al.
Cancer Gene Therapy (2021) Vol. 29, Iss. 6, pp. 647-660
Open Access | Times Cited: 67
Ramazan Rezaei, Hadi Esmaeili Gouvarchin Ghaleh, Mahdieh Farzanehpour, et al.
Cancer Gene Therapy (2021) Vol. 29, Iss. 6, pp. 647-660
Open Access | Times Cited: 67
Trial Watch:
Jonathan Pol, Norma Bloy, Florine Obrist, et al.
OncoImmunology (2014) Vol. 3, Iss. 6, pp. e28694-e28694
Open Access | Times Cited: 91
Jonathan Pol, Norma Bloy, Florine Obrist, et al.
OncoImmunology (2014) Vol. 3, Iss. 6, pp. e28694-e28694
Open Access | Times Cited: 91
The Efficacy of Oncolytic Adenovirus Is Mediated by T-cell Responses against Virus and Tumor in Syrian Hamster Model
Xiaozhu Li, Pengju Wang, Hang Li, et al.
Clinical Cancer Research (2016) Vol. 23, Iss. 1, pp. 239-249
Closed Access | Times Cited: 81
Xiaozhu Li, Pengju Wang, Hang Li, et al.
Clinical Cancer Research (2016) Vol. 23, Iss. 1, pp. 239-249
Closed Access | Times Cited: 81
Adenovirus Improves the Efficacy of Adoptive T-cell Therapy by Recruiting Immune Cells to and Promoting Their Activity at the Tumor
Siri Tähtinen, Susanna Grönberg-Vähä-Koskela, Dave Lumén, et al.
Cancer Immunology Research (2015) Vol. 3, Iss. 8, pp. 915-925
Open Access | Times Cited: 65
Siri Tähtinen, Susanna Grönberg-Vähä-Koskela, Dave Lumén, et al.
Cancer Immunology Research (2015) Vol. 3, Iss. 8, pp. 915-925
Open Access | Times Cited: 65
Oncolytic virus therapy in Japan: progress in clinical trials and future perspectives
Satoru Taguchi, Hiroshi Fukuhara, Tomoki Todo
Japanese Journal of Clinical Oncology (2018) Vol. 49, Iss. 3, pp. 201-209
Closed Access | Times Cited: 65
Satoru Taguchi, Hiroshi Fukuhara, Tomoki Todo
Japanese Journal of Clinical Oncology (2018) Vol. 49, Iss. 3, pp. 201-209
Closed Access | Times Cited: 65
Oncolytic Virus-Mediated Reversal of Impaired Tumor Antigen Presentation
Shashi Gujar, Patrick W.K. Lee
Frontiers in Oncology (2014) Vol. 4
Open Access | Times Cited: 57
Shashi Gujar, Patrick W.K. Lee
Frontiers in Oncology (2014) Vol. 4
Open Access | Times Cited: 57
STAT2 Knockout Syrian Hamsters Support Enhanced Replication and Pathogenicity of Human Adenovirus, Revealing an Important Role of Type I Interferon Response in Viral Control
Károly Tóth, Sang Ryeul Lee, Baoling Ying, et al.
PLoS Pathogens (2015) Vol. 11, Iss. 8, pp. e1005084-e1005084
Open Access | Times Cited: 54
Károly Tóth, Sang Ryeul Lee, Baoling Ying, et al.
PLoS Pathogens (2015) Vol. 11, Iss. 8, pp. e1005084-e1005084
Open Access | Times Cited: 54
Adenovirus Coding for Interleukin-2 and Tumor Necrosis Factor Alpha Replaces Lymphodepleting Chemotherapy in Adoptive T Cell Therapy
João M. Santos, Víctor Cervera-Carrascón, Riikka Havunen, et al.
Molecular Therapy (2018) Vol. 26, Iss. 9, pp. 2243-2254
Open Access | Times Cited: 50
João M. Santos, Víctor Cervera-Carrascón, Riikka Havunen, et al.
Molecular Therapy (2018) Vol. 26, Iss. 9, pp. 2243-2254
Open Access | Times Cited: 50
Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma model
Łukasz Kuryk, Elina Haavisto, Mariangela Garofalo, et al.
International Journal of Cancer (2016) Vol. 139, Iss. 8, pp. 1883-1893
Open Access | Times Cited: 48
Łukasz Kuryk, Elina Haavisto, Mariangela Garofalo, et al.
International Journal of Cancer (2016) Vol. 139, Iss. 8, pp. 1883-1893
Open Access | Times Cited: 48
Development of gene therapy for blood disorders: an update
Arthur W. Nienhuis
Blood (2013) Vol. 122, Iss. 9, pp. 1556-1564
Open Access | Times Cited: 52
Arthur W. Nienhuis
Blood (2013) Vol. 122, Iss. 9, pp. 1556-1564
Open Access | Times Cited: 52
Translational Cancer Research
Vincenzo Cerullo, Kilian Guse, Markus Vähä‐Koskela, et al.
(2014), pp. 1-20
Closed Access | Times Cited: 49
Vincenzo Cerullo, Kilian Guse, Markus Vähä‐Koskela, et al.
(2014), pp. 1-20
Closed Access | Times Cited: 49
Current status of clinical trials assessing oncolytic virus therapy for urological cancers
Satoru Taguchi, Hiroshi Fukuhara, Yukio Homma, et al.
International Journal of Urology (2017) Vol. 24, Iss. 5, pp. 342-351
Open Access | Times Cited: 47
Satoru Taguchi, Hiroshi Fukuhara, Yukio Homma, et al.
International Journal of Urology (2017) Vol. 24, Iss. 5, pp. 342-351
Open Access | Times Cited: 47
Favorable Alteration of Tumor Microenvironment by Immunomodulatory Cytokines for Efficient T-Cell Therapy in Solid Tumors
Siri Tähtinen, Saija Kaikkonen, Maiju Merisalo-Soikkeli, et al.
PLoS ONE (2015) Vol. 10, Iss. 6, pp. e0131242-e0131242
Open Access | Times Cited: 45
Siri Tähtinen, Saija Kaikkonen, Maiju Merisalo-Soikkeli, et al.
PLoS ONE (2015) Vol. 10, Iss. 6, pp. e0131242-e0131242
Open Access | Times Cited: 45
Oncolytic Adenovirus Loaded with L-carnosine as Novel Strategy to Enhance the Antitumor Activity
Mariangela Garofalo, Barbara Iovine, Łukasz Kuryk, et al.
Molecular Cancer Therapeutics (2016) Vol. 15, Iss. 4, pp. 651-660
Open Access | Times Cited: 42
Mariangela Garofalo, Barbara Iovine, Łukasz Kuryk, et al.
Molecular Cancer Therapeutics (2016) Vol. 15, Iss. 4, pp. 651-660
Open Access | Times Cited: 42
